Shopping Cart
Remove All
Your shopping cart is currently empty
Nemolizumab (CIM331) is a humanized monoclonal antibody targeting the human interleukin-31 receptor A, inhibiting IL-31 binding and subsequent signal transduction. It is useful for studying atopic dermatitis with pruritus.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $143 | In Stock | In Stock | |
| 5 mg | $343 | In Stock | In Stock | |
| 10 mg | $562 | - | In Stock | |
| 25 mg | $889 | - | In Stock | |
| 50 mg | $1,190 | - | In Stock |
| Description | Nemolizumab (CIM331) is a humanized monoclonal antibody targeting the human interleukin-31 receptor A, inhibiting IL-31 binding and subsequent signal transduction. It is useful for studying atopic dermatitis with pruritus. |
| Synonyms | CIM331 |
| Reactivity | Human |
| Verified Activity | Immobilized Human IL-31RA Protein (Fc) at 2 μg/mL (30 μL/well) can bind Nemolizumab. The EC50 is 20.79 ng/mL. |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | IL-31Ra |
| Molecular Weight | 144.92 kDa |
| Cas No. | 1476039-58-3 |
| Color | Transparent |
| Appearance | Liquid |
| Isotype | Human IgG2 kappa |
| Recommended Isotype Control |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.